Auricular Acupressure (AA) For Overweight/Obese Adolescent and Young Polycystic Ovary Syndrome ( PCOS)
Not Applicable
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Other: Placebo auricular acupressureOther: Auricular acupressure
- Registration Number
- NCT02326714
- Lead Sponsor
- Heilongjiang University of Chinese Medicine
- Brief Summary
The purpose of this trial is to investigate the effect and safety of auricular acupressure on adolescent and young women with PCOS. Subjects will be randomly assigned in to two arms: Auricular acupressure arm and placebo auricular acupressure, both arms will be treated for three months. Body mass index, oral glucose tolerance test, hormonal profile and metabolic profile will be determined.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
- Women aged between 12 and 25 years.
- Diagnosis of PCOS according to the modified Rotterdam criteria.
- 2 years after menarche.
- Body mass index (BMI) equal to or greater than 23 kg/m*m.
Exclusion Criteria
- Administration of other medications known to affect reproductive function or metabolism within the past three months, including oral contraceptives, Gonadotropin-releasing hormone (GnRH) agonists and antagonists, anti androgens, gonadotropins, anti-obesity drugs, Chinese herbal medicines, anti diabetic drugs such as metformin and thiazolidinediones, somatostatin, diazoxide, and calcium channel blockers.
- Patients with other endocrine disorders including 21-hydroxylase deficiency, hyperprolactinemia, uncorrected thyroid disease, suspected Cushing's syndrome.
- Patients with known severe organ dysfunction or mental illness.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo auricular acupressure Placebo auricular acupressure The magnetic beads will be taped to the three pressing points:Tonsil, eye and elbow. Auricular acupressure Auricular acupressure The magnetic beads will be taped to the seven pressing points: Hunger point, Ovary, Uterus, Endocrine point, liver, kidney and spleen.
- Primary Outcome Measures
Name Time Method Body mass index (BMI): BMI change at 3 months. 3 month
- Secondary Outcome Measures
Name Time Method Testosterone (T) 3 month Oral glucose tolerance test (OGTT) 3 month Luteinizing hormone (LH) 3 month Cholesterol 3 month Triglycerides (TG) 3 month Waist/hip ratio 3 month Dehydroepiandrosterone sulfate (DHEAS). 3 month Follicle stimulating hormone (FSH) 3 month Ferriman-Gallwey score 3 month Sex hormone-binding globulin (SHBG) 3 month
Trial Locations
- Locations (1)
First Affiliated Hospital, Heilongjiang University of Chinese Medicine
🇨🇳Harbin, Heilongjiang, China